ICD-10 Coding for Myeloproliferative Disease(D47.1, C94.4)
Complete ICD-10-CM coding and documentation guide for Myeloproliferative Disease. Includes clinical validation requirements, documentation requirements, and coding pitfalls.
Also known as:
Related ICD-10 Code Ranges
Complete code families applicable to Myeloproliferative Disease
D47-D47.9Primary Range
Other Neoplasms of Uncertain Behavior of Lymphoid, Hematopoietic and Related Tissue
This range includes codes for chronic myeloproliferative diseases, which are primary for this condition.
Myeloid Leukemia
Includes codes for specific myeloid leukemias that may be differentially diagnosed from myeloproliferative diseases.
Code Comparison: When to Use Each Code
Compare key differences between these codes to ensure accurate selection
| Code | Description | When to Use | Key Documentation |
|---|---|---|---|
| D47.1 | Chronic myeloproliferative disease | Use when a specific subtype of myeloproliferative disease is not identified. |
|
| C94.4 | Polycythemia vera | Use when polycythemia vera is confirmed by clinical and laboratory findings. |
|
Clinical Decision Support
Always review the patient's clinical documentation thoroughly. When in doubt, choose the more specific code and ensure documentation supports it.
Key Information: ICD-10 code for myeloproliferative disease
Essential facts and insights about Myeloproliferative Disease
Primary ICD-10-CM Codes for myeloproliferative disease
Decision Criteria
clinical Criteria
- JAK2, CALR, or MPL mutation positive
Applicable To
- Chronic eosinophilic leukemia
- Myelodysplastic/myeloproliferative neoplasm
Clinical Validation Requirements
- JAK2, CALR, or MPL mutation testing
- Bone marrow biopsy results
Code-Specific Risks
- Incorrectly using D47.1 for specific subtypes like polycythemia vera or essential thrombocythemia.
Coding Notes
- Ensure genetic testing results are documented to support the use of this code.
C94.4 - Polycythemia vera
Use when polycythemia vera is confirmed by clinical and laboratory findings.
Clinical Validation Requirements
- Hemoglobin >16.5 g/dL (men) or >16.0 g/dL (women)
- JAK2 V617F mutation positive
Coding Notes
Ensure hemoglobin levels and JAK2 mutation status are documented.
Ancillary Codes
Additional codes that should be used in conjunction with the main diagnosis codes when applicable.
Splenomegaly
R16.1Documentation & Coding Risks
Avoid these common documentation and coding issues when documenting Myeloproliferative Disease to ensure proper reimbursement, maintain compliance, and reduce audit risk. These guidelines are particularly important when using ICD-10 code D47.1.
Impact
Clinical: Inaccurate diagnosis and treatment planning., Regulatory: Non-compliance with coding standards., Financial: Potential claim denials.
Mitigation Strategy
Ensure all genetic test results are included in the patient's medical record.
Impact
Reimbursement: Incorrect reimbursement due to misclassification., Compliance: Non-compliance with coding guidelines., Data Quality: Inaccurate clinical data representation.
Mitigation Strategy
Use specific codes like C94.4 for polycythemia vera.
Impact
Lack of genetic test documentation can lead to audit risks.
Mitigation Strategy
Ensure all genetic test results are documented in the patient's record.
Documentation errors, coding pitfalls, and audit risks are interconnected aspects of medical coding and billing. Addressing all three areas helps ensure accurate coding, optimal reimbursement, and regulatory compliance.
Frequently Asked Questions
Common questions about ICD-10 coding for Myeloproliferative Disease, with expert answers to help guide accurate code selection and documentation.
Documentation Templates for Myeloproliferative Disease
Use these documentation templates to ensure complete and accurate documentation for Myeloproliferative Disease. These templates include all required elements for proper coding and billing.
Chronic myeloproliferative disease with genetic testing
Specialty: HematologyRequired Elements
- Patient demographics
- Clinical presentation
- Genetic test results
- Bone marrow biopsy findings
Example Documentation
Examples: Poor vs. Good Documentation
Poor Documentation Example
Good Documentation Example
Explanation
Need help with ICD-10 coding for Myeloproliferative Disease? Ask your questions below.